acyclovir (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the acyclovir drug offered from Cadila Healthcare Limited. This DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
| NON-PROPRIETARY NAME: | ACYCLOVIR |
| SUBSTANCE NAME: | ACYCLOVIR SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-08-17 |
| END MARKETING DATE: | 0000-00-00 |
acyclovir HUMAN PRESCRIPTION DRUG Details:
| Item Description | acyclovir from Cadila Healthcare Limited |
| LABELER NAME: | Cadila Healthcare Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500(mg/1) |
| START MARKETING DATE: | 2017-08-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70771-1081_eed2fb08-0ba5-4293-9d0e-d72ee271cc1b |
| PRODUCT NDC: | 70771-1081 |
| APPLICATION NUMBER: | ANDA206606 |
Other ACYCLOVIR SODIUM Pharmaceutical Manufacturers / Labelers:
